首页 > 最新文献

Acta Pharmaceutica最新文献

英文 中文
Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids. 揭示蒿甲素、蒿乙素和二茂铁混合物的抗胶质母细胞瘤潜力。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0033
Goran Poje, Davor Šakić, Marina Marinović, Jiangyang You, Michael Tarpley, Kevin P Williams, Nikolina Golub, Jaka Dernovšek, Tihomir Tomašič, Erim Bešić, Zrinka Rajić

The poor prognosis of glioblastoma multiforme, inadequate treatment options, and growing drug resistance urge the need to find new effective agents. Due to the significant anti-cancer potential of harmicens, hybrid compounds which comprise harmine/β-carboline and ferrocene moiety, we investigated their antiglioblastoma potential in vitro and mechanism of action (inhibition of DYRK1A, Hsp90, anti-oxidative activity). The results have shown that triazole-type harmicens, namely 5, with a ferrocene moiety in C-3 position of the β-carboline ring (IC 50 = 3.7 ± 0.1 µmol L-1, SI = 12.6) and ., the C-6 substituted harmicene (IC 50 = 7.4 ± 0.5 µmol L-1, SI = 5.8) exert remarkable activity and selectivity against human malignant glioblastoma cell line (U251) in vitro. On the other hand, amide-type harmicens 10, 12, and 14 exhibited strong, but non-selective activity, in the low micro-molar range. Mechanistic studies revealed that among active compounds, amide-type harmicens 12 and 14 inhibit DYRK1A and Hsp90 CTD, whereas compound 14 showed pronounced antioxidative activity. Therefore, the antiproliferative activity of harmicens might be a combination of complex molecular interactions.

多形性胶质母细胞瘤预后不佳,治疗方案不足,耐药性不断增加,因此需要寻找新的有效药物。鉴于蒿甲素(由蒿甲素/β-咔啉和二茂铁组成的杂化化合物)的抗癌潜力巨大,我们对其体外抗胶质母细胞瘤的潜力和作用机制(抑制 DYRK1A、Hsp90、抗氧化活性)进行了研究。结果表明,三唑类胭脂虫,即在β-咔啉环的 C-3 位具有二茂铁分子的 5(IC 50 = 3.7 ± 0.1 µmol L-1,SI = 12.6)和 C-6 取代的胭脂虫 9(IC 50 = 7.4 ± 0.5 µmol L-1,SI = 5.8),在体外对人类恶性胶质母细胞瘤细胞株(U251)具有显著的活性和选择性。另一方面,酰胺型伤害素 10、12 和 14 在低微摩尔范围内表现出很强的活性,但无选择性。机理研究表明,在活性化合物中,酰胺型蒿甲素 12 和 14 可抑制 DYRK1A 和 Hsp90 CTD,而化合物 14 则具有明显的抗氧化活性。因此,蒿甲素的抗增殖活性可能是复杂的分子相互作用的综合结果。
{"title":"Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids.","authors":"Goran Poje, Davor Šakić, Marina Marinović, Jiangyang You, Michael Tarpley, Kevin P Williams, Nikolina Golub, Jaka Dernovšek, Tihomir Tomašič, Erim Bešić, Zrinka Rajić","doi":"10.2478/acph-2024-0033","DOIUrl":"10.2478/acph-2024-0033","url":null,"abstract":"<p><p>The poor prognosis of glioblastoma multiforme, inadequate treatment options, and growing drug resistance urge the need to find new effective agents. Due to the significant anti-cancer potential of harmicens, hybrid compounds which comprise harmine/β-carboline and ferrocene moiety, we investigated their antiglioblastoma potential <i>in vitro</i> and mechanism of action (inhibition of DYRK1A, Hsp90, anti-oxidative activity). The results have shown that triazole-type harmicens, namely <b>5</b>, with a ferrocene moiety in C-3 position of the β-carboline ring (<i>IC</i> <sub>50</sub> = 3.7 ± 0.1 µmol L-1, SI = 12.6) and ., the C-6 substituted harmicene (<i>IC</i> <sub>50</sub> = 7.4 ± 0.5 µmol L-1, SI = 5.8) exert remarkable activity and selectivity against human malignant glioblastoma cell line (U251) <i>in vitro</i>. On the other hand, amide-type harmicens <b>10</b>, <b>12</b>, and <b>14</b> exhibited strong, but non-selective activity, in the low micro-molar range. Mechanistic studies revealed that among active compounds, amide-type harmicens <b>12</b> and <b>14</b> inhibit DYRK1A and Hsp90 CTD, whereas compound <b>14</b> showed pronounced antioxidative activity. Therefore, the antiproliferative activity of harmicens might be a combination of complex molecular interactions.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"595-612"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenolic content and antioxidant activity of Croatian and German honey. 克罗地亚和德国蜂蜜的酚含量和抗氧化活性。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0031
Valerija Vujčić Bok, Ivana Šola, Gordana Rusak, Alan Budisavljević, Rosa Nguyen, Jutta Ludwig-Müller, Željan Maleš

Since honey has a therapeutic role in the treatment of many diseases, we investigated the content of phenolic compounds and the antioxidant activity in acacia (Robinia pseudoacacia L.), chestnut (Castanea sativa Mill.) and lime-tree (Tilia spp.) honey originating from Croatia and Germany. Total phenols, flavonols, and flavanols contents were observed at higher levels in Croatian Castanea honey compared to German Castanea honey. Significant higher values of total flavanols and hydroxycinnamic acids were measured in Croatian Tilia honey compared to German Tilia honey. For Robinia honey, significantly higher values of total phenols and flavonols were observed in almost all Croatian honey samples compared to German honey. Croatian honey samples had higher antioxidant activity compared to German honey samples with most tested methods. The highest total phenols, total flavanols, ABTS, DPPH, and FRAP values were measured in Castanea honey, then in Robinia honey, and the lowest values in Tilia honey samples. With new developed HPLC method, pinobanksin, pinocembrin, and chrysin were identified in the majority of honey samples. Our results imply that both botanical and geographical origin influence the final quality of phenolic compounds and antioxidant activity in honey. A high positive correlation between the results of antioxidant activity and polyphenols was detected.

由于蜂蜜在治疗多种疾病方面具有治疗作用,我们研究了产自克罗地亚和德国的刺槐(Robinia pseudoacacia L.)、栗树(Castanea sativa Mill.)和椴树(Tilia spp.)蜂蜜中的酚类化合物含量和抗氧化活性。与德国蓖麻蜂蜜相比,克罗地亚蓖麻蜂蜜的总酚、黄酮醇和黄烷醇含量较高。克罗地亚椴树蜂蜜的总黄烷醇和羟基肉桂酸含量明显高于德国椴树蜂蜜。就洋槐蜂蜜而言,与德国蜂蜜相比,几乎所有克罗地亚蜂蜜样品的总酚和黄酮醇值都明显较高。在大多数测试方法中,克罗地亚蜂蜜样品的抗氧化活性高于德国蜂蜜样品。蓖麻蜂蜜的总酚、总黄烷醇、ABTS、DPPH 和 FRAP 值最高,然后是洋槐蜂蜜,而椴树蜂蜜的值最低。采用新开发的高效液相色谱法,在大多数蜂蜜样品中都鉴定出了松柏黄酮素、松柏黄酮素和菊花黄酮素。我们的研究结果表明,植物和地理产地都会影响蜂蜜中酚类化合物的最终质量和抗氧化活性。抗氧化活性与多酚类化合物之间存在高度正相关。
{"title":"Phenolic content and antioxidant activity of Croatian and German honey.","authors":"Valerija Vujčić Bok, Ivana Šola, Gordana Rusak, Alan Budisavljević, Rosa Nguyen, Jutta Ludwig-Müller, Željan Maleš","doi":"10.2478/acph-2024-0031","DOIUrl":"10.2478/acph-2024-0031","url":null,"abstract":"<p><p>Since honey has a therapeutic role in the treatment of many diseases, we investigated the content of phenolic compounds and the antioxidant activity in acacia (<i>Robinia pseudoacacia</i> L.), chestnut (<i>Castanea sativa</i> Mill.) and lime-tree (<i>Tilia</i> spp.) honey originating from Croatia and Germany. Total phenols, flavonols, and flavanols contents were observed at higher levels in Croatian <i>Castanea</i> honey compared to German <i>Castanea</i> honey. Significant higher values of total flavanols and hydroxycinnamic acids were measured in Croatian <i>Tilia</i> honey compared to German <i>Tilia</i> honey. For <i>Robinia</i> honey, significantly higher values of total phenols and flavonols were observed in almost all Croatian honey samples compared to German honey. Croatian honey samples had higher antioxidant activity compared to German honey samples with most tested methods. The highest total phenols, total flavanols, ABTS, DPPH, and FRAP values were measured in <i>Castanea</i> honey, then in <i>Robinia</i> honey, and the lowest values in <i>Tilia</i> honey samples. With new developed HPLC method, pinobanksin, pinocembrin, and chrysin were identified in the majority of honey samples. Our results imply that both botanical and geographical origin influence the final quality of phenolic compounds and antioxidant activity in honey. A high positive correlation between the results of antioxidant activity and polyphenols was detected.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"673-692"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light-induced rearrangement from macrocyclic to bicyclic lactam: A case study of N-chlorinated laurolactam. 从大环内酰胺到双环内酰胺的光诱导重排:N-chlorinated laurolactam 的案例研究。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0035
Gabrijel Zubčić, Kristina Pavić, Jiangyang You, Valerije Vrček, Tomislav Portada, Erim Bešić, Davor Šakić

Converting macrocycle lactams into bicyclic lactams is proposed as an additional way to further increase the metabolic stability of peptide-based drugs. Unfortunately, the synthesis of bicyclic lactams has to start almost from scratch. This study explores the Hofmann-Löffler-Freytag (HLF) reaction mechanism and products as a potential late-stage functionalisation strategy for facile conversion of macrocyclic to bicyclic ring. Laurolactam, a macrocyclic amide, exhibits significant potential for transformation into bioactive bicyclic structures with smaller, β-, γ-, δ-, and ε-lactam rings, further increasing rigidity and hydrolytic stability. With irradiation provided by a 370 nm lamp, light-induced rearrangement reaction was monitored using nuclear magnetic resonance (NMR), while involved radical intermediates were trapped using N-tert-butyl-α-phenylnitrone (PBN) spin-trap and characterised via EPR. While only two radical adduct types were identified in the electron para magnetic resonance (EPR) (C-centered radical and chlorine radical), all eight possible products are observed in the NMR. Quantum chemical calculations provide deeper insights into reaction thermodynamics and kinetics, explaining why the N-centered radical was not observed. This research highlights the feasibility of using the HLF reaction to transform macrocyclic lactams into stable bicyclic drug candidates, paving the way for new therapeutic developments.

将大环内酰胺转化为双环内酰胺是进一步提高肽类药物代谢稳定性的另一种方法。遗憾的是,双环内酰胺的合成几乎要从零开始。本研究探讨了霍夫曼-洛夫勒-弗雷塔格(HLF)反应机理和产物,以此作为一种潜在的后期官能化策略,实现大环到双环的便捷转化。月桂内酰胺是一种大环酰胺,具有转化为具有较小的β-、γ-、δ-和ε-内酰胺环的生物活性双环结构的巨大潜力,可进一步提高刚性和水解稳定性。在 370 nm 灯的照射下,利用核磁共振 (NMR) 对光诱导的重排反应进行监测,同时利用 N-叔丁基-α-苯基硝酮 (PBN) 自旋阱捕获所涉及的自由基中间体,并通过 EPR 对其进行表征。虽然在电子对位磁共振(EPR)中只确定了两种自由基加合物类型(C-中心自由基和氯自由基),但在核磁共振中观察到了所有八种可能的产物。量子化学计算深入揭示了反应热力学和动力学,解释了为什么没有观察到以 N 为中心的自由基。这项研究强调了利用 HLF 反应将大环内酰胺转化为稳定的双环候选药物的可行性,为新疗法的开发铺平了道路。
{"title":"Light-induced rearrangement from macrocyclic to bicyclic lactam: A case study of <i>N</i>-chlorinated laurolactam.","authors":"Gabrijel Zubčić, Kristina Pavić, Jiangyang You, Valerije Vrček, Tomislav Portada, Erim Bešić, Davor Šakić","doi":"10.2478/acph-2024-0035","DOIUrl":"10.2478/acph-2024-0035","url":null,"abstract":"<p><p>Converting macrocycle lactams into bicyclic lactams is proposed as an additional way to further increase the metabolic stability of peptide-based drugs. Unfortunately, the synthesis of bicyclic lactams has to start almost from scratch. This study explores the Hofmann-Löffler-Freytag (HLF) reaction mechanism and products as a potential late-stage functionalisation strategy for facile conversion of macrocyclic to bicyclic ring. Laurolactam, a macrocyclic amide, exhibits significant potential for transformation into bioactive bicyclic structures with smaller, β-, γ-, δ-, and ε-lactam rings, further increasing rigidity and hydrolytic stability. With irradiation provided by a 370 nm lamp, light-induced rearrangement reaction was monitored using nuclear magnetic resonance (NMR), while involved radical intermediates were trapped using <i>N</i>-<i>tert</i>-butyl-α-phenylnitrone (PBN) spin-trap and characterised <i>via</i> EPR. While only two radical adduct types were identified in the electron para magnetic resonance (EPR) (<i>C</i>-centered radical and chlorine radical), all eight possible products are observed in the NMR. Quantum chemical calculations provide deeper insights into reaction thermodynamics and kinetics, explaining why the <i>N</i>-centered radical was not observed. This research highlights the feasibility of using the HLF reaction to transform macrocyclic lactams into stable bicyclic drug candidates, paving the way for new therapeutic developments.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"725-737"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission.
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0038
Iva Marović, Mario Udovičić, Diana Rudan, Šime Manola, Ivana Samardžić, Vesna Bačić Vrca, Maja Ortner Hadžiabdić, Ivana Marinović
<p><p>Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally. It is estimated that 17.9 million people died from CVDs in 2019, which represents 32 % of all deaths worldwide. Cardiovascular drugs are the most common medical intervention for the prevention of cardiovascular events. CV medications have many benefits however their application is often complicated by multimorbidity and polypharmacy. Drug-drug interactions (DDIs) can lead to adverse drug events, hospitalizations, prolonged hospital stays, increased healthcare costs, and increased risk of mortality. Hospital admission provides an opportunity for pharmacotherapy analysis and for identifying DDIs which can jeopardize medication safety. The aim of this study is to determine the type and prevalence of potential clinically significant DDIs in patients with CVD and to examine factors associated with exposure to DDIs. A prospective study was conducted at the Dubrava University Hospital at the Clinic of Cardiology during a 6-month period (September 2023 - February 2024). Demographic, clinical and pharmacotherapy data were collected for each patient. The first prescribed pharmacotherapy was analyzed. The research was approved by the Hospital's Ethics Committee and each patient involved in the study signed an informed consent. Lexicomp<sup>®</sup> Lexi-InteractTM Online (Lexi-Comp, Inc., USA) was used for DDI analysis. Poisson regression was used for regression analysis for determining risk factors associated with exposure to DDIs. Total of 151 patients admitted to Cardiology ward were included in the research, and the average age was 67 years. Patients had an average of 9 medications in their therapy and 8 diagnoses. Overall, 1268 potential clinically significant DDIs were determined, of which the most frequently determined interactions were grade C (90.9 %), then grade D (8.6 %) and grade X (0.6 %). CV medications were involved in 88 % DDIs. The most common interventions regarding identified DDIs included exclusion one of the drugs, dose adjustment, increased monitoring of signs of bleeding, cardiac disorders, hypoglycemia, CNS depression and rhabdomyolysis, blood pressure, markers of renal function and electrolyte status. Factors associated with the prevalence of potential clinically significant DDIs were decreased renal function, recent hospitalization, total number of comorbidities and polypharmacy. Specific comorbidities associated with DDIs were arrhythmia, heart failure, diabetes mellitus and disease of the respiratory system. A high prevalence of DDIs of CV medications in all categories of clinical significance was determined. Managing medication safety in specific patient groups with CVDs can represent a greater challenge regarding DDIs. Certain medical conditions, such as arrhythmia, heart failure, diabetes, and diseases of the respiratory system, multimorbidity, polypharmacy, impaired renal function and recent hospitalization are identified in this re
{"title":"Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission.","authors":"Iva Marović, Mario Udovičić, Diana Rudan, Šime Manola, Ivana Samardžić, Vesna Bačić Vrca, Maja Ortner Hadžiabdić, Ivana Marinović","doi":"10.2478/acph-2024-0038","DOIUrl":"https://doi.org/10.2478/acph-2024-0038","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally. It is estimated that 17.9 million people died from CVDs in 2019, which represents 32 % of all deaths worldwide. Cardiovascular drugs are the most common medical intervention for the prevention of cardiovascular events. CV medications have many benefits however their application is often complicated by multimorbidity and polypharmacy. Drug-drug interactions (DDIs) can lead to adverse drug events, hospitalizations, prolonged hospital stays, increased healthcare costs, and increased risk of mortality. Hospital admission provides an opportunity for pharmacotherapy analysis and for identifying DDIs which can jeopardize medication safety. The aim of this study is to determine the type and prevalence of potential clinically significant DDIs in patients with CVD and to examine factors associated with exposure to DDIs. A prospective study was conducted at the Dubrava University Hospital at the Clinic of Cardiology during a 6-month period (September 2023 - February 2024). Demographic, clinical and pharmacotherapy data were collected for each patient. The first prescribed pharmacotherapy was analyzed. The research was approved by the Hospital's Ethics Committee and each patient involved in the study signed an informed consent. Lexicomp&lt;sup&gt;®&lt;/sup&gt; Lexi-InteractTM Online (Lexi-Comp, Inc., USA) was used for DDI analysis. Poisson regression was used for regression analysis for determining risk factors associated with exposure to DDIs. Total of 151 patients admitted to Cardiology ward were included in the research, and the average age was 67 years. Patients had an average of 9 medications in their therapy and 8 diagnoses. Overall, 1268 potential clinically significant DDIs were determined, of which the most frequently determined interactions were grade C (90.9 %), then grade D (8.6 %) and grade X (0.6 %). CV medications were involved in 88 % DDIs. The most common interventions regarding identified DDIs included exclusion one of the drugs, dose adjustment, increased monitoring of signs of bleeding, cardiac disorders, hypoglycemia, CNS depression and rhabdomyolysis, blood pressure, markers of renal function and electrolyte status. Factors associated with the prevalence of potential clinically significant DDIs were decreased renal function, recent hospitalization, total number of comorbidities and polypharmacy. Specific comorbidities associated with DDIs were arrhythmia, heart failure, diabetes mellitus and disease of the respiratory system. A high prevalence of DDIs of CV medications in all categories of clinical significance was determined. Managing medication safety in specific patient groups with CVDs can represent a greater challenge regarding DDIs. Certain medical conditions, such as arrhythmia, heart failure, diabetes, and diseases of the respiratory system, multimorbidity, polypharmacy, impaired renal function and recent hospitalization are identified in this re","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"693-708"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the suspension procedure by Box-Behnken design for the determination of manganese, iron, and zinc in zeolite clinoptilolite with the TXRF system and insight into its antioxidant properties.
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0040
Jasna Jablan, Maja Bival Štefan, Dario Paler, Emma Kamenski

Zeolites are a large family of minerals and the most studied is the naturally occurring clinoptilolite. They possess anti-inflammatory, antioxidant, and detoxifying properties which makes them valuable for medicinal use. Element analysis of zeolite's composition is necessary for its precise chemical characterization, and within this work development of a suspension method for the determination of manga nese, iron, and zinc by total reflection X-ray fluorescence spec-trometry (TXRF) was presented. The Box-Behnken design based on the response surface methodology was applied to determine the optimal sample preparation conditions. The significant variables such as sample amount, volume deposition, and dispersant were selected as critical variables. Based on the results obtained, sample suspensions were prepared by weighing 10 mg of the sample and adding 1 mL of 5 % Triton X-100 with 10 mL Ga as internal standard and deposition volume was set at 10 mL. The results obtained with TXRF were comparable with those obtained with the FAAS method, indicating that this technique can be used instead of the conventional methods. Using the best analytical conditions, the limits of detection for trace elements were in the range of 0.2-0.6 mg kg-1. Trueness and precision of the results, evaluated by CRM sample analysis, were in most cases acceptable with recoveries values in the range of 104.9-111.4 % and relative standard deviations of 2-10 % (. = 6). Zeolites showed no ability to quench free radicals nor the ability to influence dietary antioxidants.

{"title":"Optimization of the suspension procedure by Box-Behnken design for the determination of manganese, iron, and zinc in zeolite clinoptilolite with the TXRF system and insight into its antioxidant properties.","authors":"Jasna Jablan, Maja Bival Štefan, Dario Paler, Emma Kamenski","doi":"10.2478/acph-2024-0040","DOIUrl":"https://doi.org/10.2478/acph-2024-0040","url":null,"abstract":"<p><p>Zeolites are a large family of minerals and the most studied is the naturally occurring clinoptilolite. They possess anti-inflammatory, antioxidant, and detoxifying properties which makes them valuable for medicinal use. Element analysis of zeolite's composition is necessary for its precise chemical characterization, and within this work development of a suspension method for the determination of manga nese, iron, and zinc by total reflection X-ray fluorescence spec-trometry (TXRF) was presented. The Box-Behnken design based on the response surface methodology was applied to determine the optimal sample preparation conditions. The significant variables such as sample amount, volume deposition, and dispersant were selected as critical variables. Based on the results obtained, sample suspensions were prepared by weighing 10 mg of the sample and adding 1 mL of 5 % Triton X-100 with 10 mL Ga as internal standard and deposition volume was set at 10 mL. The results obtained with TXRF were comparable with those obtained with the FAAS method, indicating that this technique can be used instead of the conventional methods. Using the best analytical conditions, the limits of detection for trace elements were in the range of 0.2-0.6 mg kg<sup>-1</sup>. Trueness and precision of the results, evaluated by CRM sample analysis, were in most cases acceptable with recoveries values in the range of 104.9-111.4 % and relative standard deviations of 2-10 % (. = 6). Zeolites showed no ability to quench free radicals nor the ability to influence dietary antioxidants.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"655-672"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in electron paramagnetic resonance (EPR) spectroscopy: A comprehensive tool for pharmaceutical research.
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0037
Erim Bešić, Zrinka Rajić, Davor Šakić

Electron paramagnetic resonance (EPR) spectroscopy has long been established across various scientific disciplines for characterizing organic radicals, organometallic complexes, protein structures and dynamics, polymerization processes, and radical degradation phenomena. Despite its extensive utility in these areas, EPR spectroscopy's application within pharmaceutical science has historically been constrained, primarily due to factors such as high equipment costs, a steep learning curve, complex spectral deconvolution and analysis, and a traditional lack of emphasis on single-electron chemistry in pharmaceutical research. This review aims to provide a thorough examination of EPR spectroscopy's applications in analyzing a wide array of para-magnetic species relevant to pharmaceutical research. We detail how EPR spectroscopy can be employed to assess free radical scavenging properties in pharmaceutical compounds, elucidate drug mechanisms of action, and explore pharmacokinetics. Additionally, we investigate the role of free radicals in drug-induced toxicity and drug-membrane interactions, while also covering the application of EPR spectroscopy in drug delivery research, advanced studies of metallodrugs, and monitoring of oxygen levels in biological systems through EPR oximetry. The recent advancements in the miniaturization of EPR spectro meters have paved the way for their application in on-site and in-line mo nitoring during the manufacturing process and quality control of pharmaceutical substances and final drug formulations due to being the only direct and non-invasive detection technique for radical detection. Through these discussions, we highlight the substantial contributions of EPR spectroscopy to the advancement of pharmaceutical sciences.

{"title":"Advancements in electron paramagnetic resonance (EPR) spectroscopy: A comprehensive tool for pharmaceutical research.","authors":"Erim Bešić, Zrinka Rajić, Davor Šakić","doi":"10.2478/acph-2024-0037","DOIUrl":"10.2478/acph-2024-0037","url":null,"abstract":"<p><p>Electron paramagnetic resonance (EPR) spectroscopy has long been established across various scientific disciplines for characterizing organic radicals, organometallic complexes, protein structures and dynamics, polymerization processes, and radical degradation phenomena. Despite its extensive utility in these areas, EPR spectroscopy's application within pharmaceutical science has historically been constrained, primarily due to factors such as high equipment costs, a steep learning curve, complex spectral deconvolution and analysis, and a traditional lack of emphasis on single-electron chemistry in pharmaceutical research. This review aims to provide a thorough examination of EPR spectroscopy's applications in analyzing a wide array of para-magnetic species relevant to pharmaceutical research. We detail how EPR spectroscopy can be employed to assess free radical scavenging properties in pharmaceutical compounds, elucidate drug mechanisms of action, and explore pharmacokinetics. Additionally, we investigate the role of free radicals in drug-induced toxicity and drug-membrane interactions, while also covering the application of EPR spectroscopy in drug delivery research, advanced studies of metallodrugs, and monitoring of oxygen levels in biological systems through EPR oximetry. The recent advancements in the miniaturization of EPR spectro meters have paved the way for their application in <i>on-site</i> and <i>in-line</i> mo nitoring during the manufacturing process and quality control of pharmaceutical substances and final drug formulations due to being the only direct and non-invasive detection technique for radical detection. Through these discussions, we highlight the substantial contributions of EPR spectroscopy to the advancement of pharmaceutical sciences.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"551-594"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project. 在社区居住的老年患者中,增加跌倒风险的药物和相关健康结果:欧洲老龄化 H2020 项目克罗地亚队列横断面研究。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0034
Elizabeta Paar, Eleonora De Lai, Margita Držaić, Ingrid Kummer, Iva Bužančić, Maja Ortner Hadžiabdić, Jovana Brkic, Daniela Fialová

Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the "Screening Tool of Older Persons Prescriptions in older adults with high fall risk" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (p < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); p = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); p = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.

我们的研究旨在评估在克罗地亚社区居住的老年患者样本中增加跌倒风险药物(FRIDs)的使用率及其与不良健康后果之间的关系。我们对克罗地亚三个不同地区的社区药房就诊的老年患者(65 岁以上)进行了横断面观察研究。数据的收集使用了一份为此目的开发的调查问卷,其中包括老年病综合评估的内容。使用 "高跌倒风险老年人处方筛查工具"(STOPPFall)确定了 FRID 的患病率。在 407 名参与者(中位数年龄为 73(IQR 69-70)岁;63.9% 为女性)中,79.1% 至少使用过一种 FRID。最常见的药物类别是利尿剂、苯二氮卓类药物和阿片类药物(分别占 51.1%、38.1% 和 17.2%)。最年长的老年患者(85 岁以上)和来自克罗地亚较贫困地区(斯拉沃尼亚)的参与者处方的 FRIDs 较多(P < 0.05)。接触 FRIDs 被认为是与跌倒(OR = 1.24 (1.04-1.50); p = 0.020)和更高的医疗保健使用率(OR = 1.29 (1.10-1.51); p = 0.001)相关的重要风险因素。我们的研究强调了合理使用 FRID 的必要性。为了减少老年人不必要地接触 FRIDs,医护人员必须考虑在选择、剂量和仅必要的 FRIDs 组合方面高度个性化的用药方案。
{"title":"Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project.","authors":"Elizabeta Paar, Eleonora De Lai, Margita Držaić, Ingrid Kummer, Iva Bužančić, Maja Ortner Hadžiabdić, Jovana Brkic, Daniela Fialová","doi":"10.2478/acph-2024-0034","DOIUrl":"10.2478/acph-2024-0034","url":null,"abstract":"<p><p>Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the \"Screening Tool of Older Persons Prescriptions in older adults with high fall risk\" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (<i>p</i> < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); <i>p</i> = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); <i>p</i> = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"635-653"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their pharmaceutical significance. 克罗地亚杂交矮牵牛及相关物种的总酚含量、类黄酮含量和抗氧化潜力,以及对其制药意义的考虑。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0032
Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš

Extracts obtained from common butterbur (Petasites hybridus), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian Petasites species (four P. hybridus, four P. albus, one P. kabli kianus, and one P. paradoxus) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g-1 dry mass (mg GAE g-1 DM) for P. hybridus and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 7.56 ± 0.17 mg GAE g-1 DM and 10.22 ± 0.46 mg GAE g-1 DM, respectively. Flavonoid content (AlCl3 assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g-1 dry mass (mg QE g-1 DM) for P. hybridus and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 5.59 ± 0.05 mg QE g-1 DM and 5.50 ± 0.09 mg QE g-1 DM, respectively. Antioxidant potential was in high correlation with total phenolic content (r = 0.93, p < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.

从普通毛茛(Petasites hybridus)中提取的提取物(标准化为 petasins)是治疗和/或预防过敏性鼻炎(叶片)和偏头痛(根茎)的现有药物选择。本研究比较了通过超声辅助萃取叶片获得的十种克罗地亚矮牵牛样本(四种杂交矮牵牛、四种白矮牵牛、一种卡布利矮牵牛和一种矛盾矮牵牛)的总酚含量、类黄酮含量和抗氧化潜力。杂交种 P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 4.43 ± 0.09 至 10.76 ± 0.60 mg 没食子酸当量 g-1 干重(mg GAE g-1 DM),P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 6.66 ± 0.43 至 19.92 ± 2.90 mg GAE g-1 DM,而 P. kablikianus 和 P. paradoxus 的含量分别为 7.56 ± 0.17 mg GAE g-1 DM 和 10.22 ± 0.46 mg GAE g-1 DM。黄酮类化合物含量(AlCl3 检测法)的变化范围为:杂交种 P. 样品介于 2.51 ± 0.10 和 4.03 ± 0.08 毫克槲皮素当量 g-1 干重(mg QE g-1 DM)之间,白头翁 P. 样品介于 2.21 ± 0.09 和 5.22 ± 0.02 毫克 QE g-1 DM 之间,而卡布力翁 P. 样品和矛盾翁 P. 样品的黄酮类化合物含量分别为 5.59 ± 0.05 毫克 QE g-1 DM 和 5.50 ± 0.09 毫克 QE g-1 DM。抗氧化潜力与总酚含量高度相关(r = 0.93,p < 0.001)。由于植物多酚和类黄酮对毛茛提取物活性的预期贡献及其观察到的巨大差异,确定这些化合物的含量可能对制药业有意义。
{"title":"Total phenolic content, flavonoid content and antioxidant potential of <i>Petasites hybridus</i> and related species from Croatia and considerations regarding their pharmaceutical significance.","authors":"Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš","doi":"10.2478/acph-2024-0032","DOIUrl":"10.2478/acph-2024-0032","url":null,"abstract":"<p><p>Extracts obtained from common butterbur (<i>Petasites hybridus</i>), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian <i>Petasites</i> species (four <i>P. hybridus</i>, four <i>P. albus</i>, one <i>P. kabli kianus</i>, and one <i>P. paradoxus</i>) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g<sup>-1</sup> dry mass (mg GAE g<sup>-1</sup> DM) for <i>P. hybridus</i> and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 7.56 ± 0.17 mg GAE g<sup>-1</sup> DM and 10.22 ± 0.46 mg GAE g<sup>-1</sup> DM, respectively. Flavonoid content (AlCl<sub>3</sub> assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g<sup>-1</sup> dry mass (mg QE g<sup>-1</sup> DM) for <i>P. hybridus</i> and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 5.59 ± 0.05 mg QE g<sup>-1</sup> DM and 5.50 ± 0.09 mg QE g<sup>-1</sup> DM, respectively. Antioxidant potential was in high correlation with total phenolic content (<i>r</i> = 0.93, <i>p</i> < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"709-723"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urban parks biowaste as a sustainable source of new antidiabetics.
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0039
Marijan Marijan, Lejsa Jakupović, Lovorka Vujić, Marina Jurić, Marijana Zovko Končić

Biowaste produced in urban parks is composed of large masses of organic matter that is only occasionally used economically. In this work, extracts of six plants widely distributed in urban parks in Central Europe (Achillea millefolium, Cichorium intybus, Malva sylvestris, Medicago sativa, Plantago lanceolata, and Trifolium pratense), prepared using 10 % and 50 % ethanol, were screened for their antidiabetic and related properties. HPLC and UV-Vis analysis revealed the presence of caffeic acid, quercetin, luteolin, and apigenin derivatives. The extracts were active in DPPH antiradical, .-carotene-linoleic acid, ORAC, and reducing power assay. They inhibited lipoxygenase, collagenase, as well as heat-induced ovalbumin coagulation. They were also able to hinder carbohydrate degradation. For example, IC 50 of anti-α-amylase activity of 10 % and 50 % ethanol extract of M. sativa extracts (204.10 ± 2.11 µg mL-1 and 78.27 ± 0.99 µg mL-1, respectively) did not statistically differ from the activity of the positive control, acarbose (284.74 ± 3.81 µg mL-1). Similar results were observed for their anti-.-glucosidase activity. In most assays, the use of 50 % ethanol was shown to be better suited for the extraction of active metabolites. The results indicate that the biowaste obtained from urban parks represents a potential source of plant material for the preparation of high-value antidiabetic products.

{"title":"Urban parks biowaste as a sustainable source of new antidiabetics.","authors":"Marijan Marijan, Lejsa Jakupović, Lovorka Vujić, Marina Jurić, Marijana Zovko Končić","doi":"10.2478/acph-2024-0039","DOIUrl":"https://doi.org/10.2478/acph-2024-0039","url":null,"abstract":"<p><p>Biowaste produced in urban parks is composed of large masses of organic matter that is only occasionally used economically. In this work, extracts of six plants widely distributed in urban parks in Central Europe (<i>Achillea millefolium</i>, <i>Cichorium intybus</i>, <i>Malva sylvestris</i>, <i>Medicago sativa</i>, <i>Plantago lanceolata</i>, and <i>Trifolium pratense</i>), prepared using 10 % and 50 % ethanol, were screened for their antidiabetic and related properties. HPLC and UV-Vis analysis revealed the presence of caffeic acid, quercetin, luteolin, and apigenin derivatives. The extracts were active in DPPH antiradical, .-carotene-linoleic acid, ORAC, and reducing power assay. They inhibited lipoxygenase, collagenase, as well as heat-induced ovalbumin coagulation. They were also able to hinder carbohydrate degradation. For example, <i>IC</i> <sub>50</sub> of anti-<i>α</i>-amylase activity of 10 % and 50 % ethanol extract of <i>M. sativa</i> extracts (204.10 ± 2.11 µg mL-1 and 78.27 ± 0.99 µg mL-1, respectively) did not statistically differ from the activity of the positive control, acarbose (284.74 ± 3.81 µg mL<sup>-1</sup>). Similar results were observed for their anti-.-glucosidase activity. In most assays, the use of 50 % ethanol was shown to be better suited for the extraction of active metabolites. The results indicate that the biowaste obtained from urban parks represents a potential source of plant material for the preparation of high-value antidiabetic products.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"613-633"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma. 结直肠癌患者的全血细胞计数参数和炎症相关生物标记物。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0036
Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković

The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (p < 0.001), compared to patients with adenomas. Total leukocyte count (p = 0 .006), absolute neutrophils (p = 0.005), and absolute monocytes (p = 0.007) were lower while relative eosinophils (p = 0.001) and relative basophils (p = 0.001) were higher in CRC patients. Platelet count (p < 0.001) was significantly higher and MPV (p = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (p < 0.001) was significantly lower and PLR (p < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.

本研究旨在确定结直肠癌(CRC)患者和结直肠腺瘤患者的全血细胞计数参数(CBC)和炎症相关生物标志物 MPV/PC、PLR、NLR、LWR、LMR、NMR 和 LCR 是否存在差异。研究包括 155 名患者,根据组织病理学分析将他们分为两组--74 名腺瘤患者和 81 名 CRC 患者。CBC 的常规检查在 Sysmex XN1000 上进行,而 CRP 则在 Alinity ci-series 上测量。统计分析采用 MedCalc 统计软件进行 ROC 曲线分析。与腺瘤患者相比,CRC 患者的血红蛋白浓度、血细胞比容、MCV、MCH 和 MCHC 较低,而 RDW 较高(p < 0.001)。CRC 患者的白细胞总数(p = 0 .006)、中性粒细胞绝对数(p = 0.005)和单核细胞绝对数(p = 0.007)较低,而嗜酸性粒细胞相对数(p = 0.001)和嗜碱性粒细胞相对数(p = 0.001)较高。CRC 患者的血小板计数(p < 0.001)明显较高,MPV(p = 0.003)明显较低。此外,在 CRC 患者中,MPV/PC(p < 0.001)明显较低,PLR(p < 0.001)明显较高。此外,受试者操作特征(ROC)分析表明,所有测试参数的诊断准确性都很低(AUC 为 0.7 或更低)。研究组间的 PC、MPV、MPV/PC 和 PLR 有显著差异,但 ROC 分析显示诊断准确性较差。CRC 患者的血红蛋白水平较低,这可能是由于出血次数较多、出血量较大所致。CRC 患者嗜碱性粒细胞和嗜酸性粒细胞水平较高,这表明炎症反应与 CRC 有关。
{"title":"Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma.","authors":"Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković","doi":"10.2478/acph-2024-0036","DOIUrl":"10.2478/acph-2024-0036","url":null,"abstract":"<p><p>The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (<i>p</i> < 0.001), compared to patients with adenomas. Total leukocyte count (<i>p</i> = 0 .006), absolute neutrophils (<i>p</i> = 0.005), and absolute monocytes (<i>p</i> = 0.007) were lower while relative eosinophils (<i>p</i> = 0.001) and relative basophils (<i>p</i> = 0.001) were higher in CRC patients. Platelet count (<i>p</i> < 0.001) was significantly higher and MPV (<i>p</i> = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (<i>p</i> < 0.001) was significantly lower and PLR (<i>p</i> < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"739-749"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Pharmaceutica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1